-
1
-
-
33646442046
-
Increasing incidence of thyroid cancer in the United States, 1973-2002
-
Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006;295:2164-7.
-
(2006)
JAMA
, vol.295
, pp. 2164-2167
-
-
Davies, L.1
Welch, H.G.2
-
2
-
-
0032535770
-
A National Cancer Data Base report on 53 856 cases of thyroid carcinoma treated in the U.S., 1985-1995
-
Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53 856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer 1998;83:2638-48.
-
(1998)
Cancer
, vol.83
, pp. 2638-2648
-
-
Hundahl, S.A.1
Fleming, I.D.2
Fremgen, A.M.3
Menck, H.R.4
-
3
-
-
0032576677
-
Papillary and follicular thyroid carcinoma
-
Schlumberger MJ. Papillary and follicular thyroid carcinoma. N Engl J Med 1998;338:297-306.
-
(1998)
N Engl J Med
, vol.338
, pp. 297-306
-
-
Schlumberger, M.J.1
-
4
-
-
17244373331
-
Variables predicting distant metastases in thyroid cancer
-
Clark JR, Lai P, Hall F, Borglund A, Eski S, Freeman JL. Variables predicting distant metastases in thyroid cancer. Laryngoscope 2005;115:661-7.
-
(2005)
Laryngoscope
, vol.115
, pp. 661-667
-
-
Clark, J.R.1
Lai, P.2
Hall, F.3
Borglund, A.4
Eski, S.5
Freeman, J.L.6
-
5
-
-
0027429811
-
Different features of pulmonary metastases in differentiated thyroid cancer: Natural history and multivariate statistical analysis of prognostic variables
-
Casara D, Rubello D, Saladini G, Masarotto G, Favero A, Girelli ME et al. Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables. J Nucl Med 1993,34:1626-31.
-
(1993)
J Nucl Med
, vol.34
, pp. 1626-1631
-
-
Casara, D.1
Rubello, D.2
Saladini, G.3
Masarotto, G.4
Favero, A.5
Girelli, M.E.6
-
6
-
-
0033310359
-
Immediate causes of death in thyroid carcinoma clinicopathological analysis of 161 fatal cases
-
Kitamura Y, Shimizu K, Nagahama M, Sugino K, Ozaki O, Mimura T et al. Immediate causes of death in thyroid carcinoma: clinicopathological analysis of 161 fatal cases. J Clin Endocrinol Metab 1999;84:4043-9.
-
(1999)
J Clin Endocrinol Metab
, vol.84
, pp. 4043-4049
-
-
Kitamura, Y.1
Shimizu, K.2
Nagahama, M.3
Sugino, K.4
Ozaki, O.5
Mimura, T.6
-
7
-
-
0033401991
-
Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases
-
Lin JD, Huang MJ, Juang JH, Chao TC, Huang BY, Chen KW et al. Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases. Thyroid 1999;9:1227-35.
-
(1999)
Thyroid
, vol.9
, pp. 1227-1235
-
-
Lin, J.D.1
Huang, M.J.2
Juang, J.H.3
Chao, T.C.4
Huang, B.Y.5
Chen, K.W.6
-
9
-
-
33745775455
-
Differentiated thyroid carcinoma how to improve the long-term results? Twenty-five-year outcomes of 850 patients
-
Melliere D, Hindie E, Becquemin JP, Desgranges P, Allaire E, Geachan E. Differentiated thyroid carcinoma how to improve the long-term results? Twenty-five-year outcomes of 850 patients. Bull Acad Natl Med 2006;190:89-106.
-
(2006)
Bull Acad Natl Med
, vol.190
, pp. 89-106
-
-
Melliere, D.1
Hindie, E.2
Becquemin, J.P.3
Desgranges, P.4
Allaire, E.5
Geachan, E.6
-
10
-
-
33645465719
-
Management guidelines for patients with thyroid nodules and differentiated thyroid cancer
-
Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006;16:109-42.
-
(2006)
Thyroid
, vol.16
, pp. 109-142
-
-
Cooper, D.S.1
Doherty, G.M.2
Haugen, B.R.3
Kloos, R.T.4
Lee, S.L.5
Mandel, S.J.6
-
11
-
-
33745684505
-
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium
-
DOI 10.1530/eje.1.02158
-
Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W; European Thyroid Cancer Taskforce. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006;154:787-803. (Pubitemid 43997716)
-
(2006)
European Journal of Endocrinology
, vol.154
, Issue.6
, pp. 787-803
-
-
Pacini, F.1
Schlumberger, M.2
Dralle, H.3
Elisei, R.4
Smit, J.W.A.5
Wiersinga, W.6
Moreno-Reyes, R.7
Van Den Bruel, A.8
Zira, C.9
Feldt-Rasmussen, U.10
Godballe, C.11
Corone, C.12
Borson-Charzot, F.13
Reiners, C.14
Alevizaki, M.15
Duntas, L.16
Vlassopoulou, B.17
Esik, O.18
Mezosi, E.19
Moriarty, M.J.20
Smyth, P.21
Cohen, O.22
Krausz, Y.23
Pellegriti, G.24
Castagna, M.G.25
Marga, M.26
Bioro, T.27
Jarzab, B.28
Carrilho, F.29
De Castro, J.J.30
Limbert, E.S.31
Ioachim, D.32
Mogos, V.33
Ursu, H.34
Roumiantsev, P.35
Troshina, E.36
Hnilica, P.37
Besic, N.38
Zagar, I.39
Gomez, J.M.40
Sanchez-Franco, F.41
Berg, G.42
Tennvall, J.43
Wallin, G.K.44
Meier, C.A.45
Links, T.P.46
Ayvaz, G.47
Uysal, A.R.48
Cherenko, S.49
Larin, O.50
Harmer, C.51
more..
-
12
-
-
41349118543
-
Bone metastases from differentiated thyroid carcinoma
-
DOI 10.1677/ERC-07-0229
-
Muresan MM, Olivier P, Leclère J, Sirveaux F, Brunaud L, Klein M et al. Bone metastases from differentiated thyroid carcinoma. Endocr Relat Cancer 2008;15:37-49. (Pubitemid 351449726)
-
(2008)
Endocrine-Related Cancer
, vol.15
, Issue.1
, pp. 37-49
-
-
Muresan, M.M.1
Olivier, P.2
Leclere, J.3
Sirveaux, F.4
Brunaud, L.5
Klein, M.6
Zarnegar, R.7
Weryha, G.8
-
13
-
-
33747642244
-
Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: Benefits and limits of radioiodine therapy
-
Durante C, Haddy N, Baudin E, Leboulleux S, Hartl D, Travagli JP et al. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab 2006;91:2892-9.
-
(2006)
J Clin Endocrinol Metab
, vol.91
, pp. 2892-2899
-
-
Durante, C.1
Haddy, N.2
Baudin, E.3
Leboulleux, S.4
Hartl, D.5
Travagli, J.P.6
-
14
-
-
29144520426
-
Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: A qualitative review
-
Jarzab B, Handkiewicz-Junak D, Wloch J. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review. Endocr Relat Cancer 2005;12:773-803.
-
(2005)
Endocr Relat Cancer
, vol.12
, pp. 773-803
-
-
Jarzab, B.1
Handkiewicz-Junak, D.2
Wloch, J.3
-
15
-
-
0027421309
-
Prognostic importance of various clinicopathological features in papillary thyroid carcinoma
-
Akslen LA, Myking AO, Salvesen H, Varhaug JE. Prognostic importance of various clinicopathological features in papillary thyroid carcinoma. Eur J Cancer 1992;29A:44-51.
-
(1992)
Eur J Cancer
, vol.29 A
, pp. 44-51
-
-
Akslen, L.A.1
Myking, A.O.2
Salvesen, H.3
Varhaug, J.E.4
-
16
-
-
41549162818
-
Papillary thyroid carcinoma: Factors influencing recurrence and survival
-
Toniato A, Boschin I, Casara D, Mazzarotto R, Rubello D, Pelizzo M. Papillary thyroid carcinoma: factors influencing recurrence and survival. Ann Surg Oncol 2008;15:1518-22.
-
(2008)
Ann Surg Oncol
, vol.15
, pp. 1518-1522
-
-
Toniato, A.1
Boschin, I.2
Casara, D.3
Mazzarotto, R.4
Rubello, D.5
Pelizzo, M.6
-
17
-
-
0031440829
-
The role of radioactive iodine in the treatment of advanced differentiated thyroid carcinoma
-
Pelikan DM, Lion HL, Hermans J, Goslings BM. The role of radioactive iodine in the treatment of advanced differentiated thyroid carcinoma. Clin Endocrinol (Oxf) 1997;47:713-20. (Pubitemid 28046560)
-
(1997)
Clinical Endocrinology
, vol.47
, Issue.6
, pp. 713-720
-
-
Pelikan, D.M.V.1
Lion, H.L.2
Hermans, J.3
Goslings, B.M.4
-
18
-
-
0031798686
-
Clinical forms of presentation and evolution of diffuse sclerosing variant of papillary carcinoma and insular variant of follicular carcinoma of the thyroid
-
Albareda M, Puig-Domingo M, Wengrowicz S, Soldevila J, Matias-Guiu X, Caballero A et al. Clinical forms of presentation and evolution of diffuse sclerosing variant of papillary carcinoma and insular variant of follicular carcinoma of the thyroid. Thyroid 1998;8:385-91.
-
(1998)
Thyroid
, vol.8
, pp. 385-391
-
-
Albareda, M.1
Puig-Domingo, M.2
Wengrowicz, S.3
Soldevila, J.4
Matias-Guiu, X.5
Caballero, A.6
-
19
-
-
0019522882
-
Papillary thyroid carcinoma: A 10 year follow-up report of the impact of therapy in 576 patients
-
Mazzaferri EL, Young RL. Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am J Med 1981;70:511-8.
-
(1981)
Am J Med
, vol.70
, pp. 511-518
-
-
Mazzaferri, E.L.1
Young, R.L.2
-
20
-
-
33646120105
-
Invasive well-differentiated thyroid carcinoma: Effect of treatment modalities on outcome
-
Segal K, Shpitzer T, Hazan A, Bachar G, Marshak G, Popovtzer A. Invasive well-differentiated thyroid carcinoma: effect of treatment modalities on outcome. Otolaryngol Head Neck Surg 2006;34:819-22.
-
(2006)
Otolaryngol Head Neck Surg
, vol.34
, pp. 819-822
-
-
Segal, K.1
Shpitzer, T.2
Hazan, A.3
Bachar, G.4
Marshak, G.5
Popovtzer, A.6
-
21
-
-
26244467655
-
Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis
-
Leboulleux S, Rubino C, Baudin E, Caillou B, Hartl DM, Bidart JM et al. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab 2005;90:5723-9.
-
(2005)
J Clin Endocrinol Metab
, vol.90
, pp. 5723-5729
-
-
Leboulleux, S.1
Rubino, C.2
Baudin, E.3
Caillou, B.4
Hartl, D.M.5
Bidart, J.M.6
-
22
-
-
85047681191
-
Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer
-
Mazzaferri EL, Kloos RT. Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001;86:1447-63.
-
(2001)
J Clin Endocrinol Metab
, vol.86
, pp. 1447-1463
-
-
Mazzaferri, E.L.1
Kloos, R.T.2
-
23
-
-
8744240542
-
Prognostic factors associated with the survival of patients developing locoregional recurrences of differentiated thyroid carcinomas
-
Rouxel A, Hejblum G, Bernier MO, Boëlle PY, Ménégaux F, Mansour G et al. Prognostic factors associated with the survival of patients developing locoregional recurrences of differentiated thyroid carcinomas. J Clin Endocrinol Metab 2004;89:5362-8.
-
(2004)
J Clin Endocrinol Metab
, vol.89
, pp. 5362-5368
-
-
Rouxel, A.1
Hejblum, G.2
Bernier, M.O.3
Boëlle, P.Y.4
Ménégaux, F.5
Mansour, G.6
-
24
-
-
0027943619
-
Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer
-
Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994;97:418-28.
-
(1994)
Am J Med
, vol.97
, pp. 418-428
-
-
Mazzaferri, E.L.1
Jhiang, S.M.2
-
25
-
-
0035143839
-
Identifying differentially expressed genes associated with metastasis of follicular thyroid cancer by cDNA expression array
-
Chen KT, Lin JD, Chao TC, Hsueh C, Chang CA, Weng HF et al. Identifying differentially expressed genes associated with metastasis of follicular thyroid cancer by cDNA expression array. Thyroid 2001;11:41-6.
-
(2001)
Thyroid
, vol.11
, pp. 41-46
-
-
Chen, K.T.1
Lin, J.D.2
Chao, T.C.3
Hsueh, C.4
Chang, C.A.5
Weng, H.F.6
-
27
-
-
34548192281
-
The prevalence and prognostic value of BRAF mutation in thyroid cancer
-
Kebebew E, Weng J, Bauer J, Ranvier G, Clark OH, Duh QY et al. The prevalence and prognostic value of BRAF mutation in thyroid cancer. Ann Surg 2007;246:466-70.
-
(2007)
Ann Surg
, vol.246
, pp. 466-470
-
-
Kebebew, E.1
Weng, J.2
Bauer, J.3
Ranvier, G.4
Clark, O.H.5
Duh, Q.Y.6
-
28
-
-
42949099868
-
Consensus conference: Management of differentiated cancers of the thyroid vesicular structure
-
Paris
-
Consensus conference: management of differentiated cancers of the thyroid vesicular structure. Ann Endocrinol (Paris) 2007;68(Suppl 2):S53-6.
-
(2007)
Ann Endocrinol
, vol.68
, Issue.SUPPL. 2
-
-
-
29
-
-
33947209465
-
Which thyroid cancer patients need periodic stimulation tests?
-
Zanotti-Fregonara P, Khoury A, Duron F, Keller I, Christin-Maître S, Kiffel T et al. Which thyroid cancer patients need periodic stimulation tests? Eur J Nucl Med Mol Imaging 2007;34:541-6.
-
(2007)
Eur J Nucl Med Mol Imaging
, vol.34
, pp. 541-546
-
-
Zanotti-Fregonara, P.1
Khoury, A.2
Duron, F.3
Keller, I.4
Christin-Maître, S.5
Kiffel, T.6
-
30
-
-
33845277378
-
Radio-guided surgery for non-131I-avid thyroid cancer
-
Rubello D, Pelizzo MR, Casara D, Piotto A, Toniato A, Fig L et al. Radio-guided surgery for non-131I-avid thyroid cancer. Thyroid 2006;16:1105-11.
-
(2006)
Thyroid
, vol.16
, pp. 1105-1111
-
-
Rubello, D.1
Pelizzo, M.R.2
Casara, D.3
Piotto, A.4
Toniato, A.5
Fig, L.6
-
32
-
-
0031724072
-
External-beam radiation therapy in the treatment of differentiated thyroid cancer
-
Brierley JD, Tsang RW. External-beam radiation therapy in the treatment of differentiated thyroid cancer. Semin Surg Oncol 1999;16:42-9.
-
(1999)
Semin Surg Oncol
, vol.16
, pp. 42-49
-
-
Brierley, J.D.1
Tsang, R.W.2
-
33
-
-
0029896016
-
Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy
-
Vassilopoulou-Sellin R, Schultz PN, Haynie TP. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy. Cancer 1996;78:493-501.
-
(1996)
Cancer
, vol.78
, pp. 493-501
-
-
Vassilopoulou-Sellin, R.1
Schultz, P.N.2
Haynie, T.P.3
-
34
-
-
33846490718
-
New therapeutic approaches for metastatic thyroid carcinoma
-
Baudin E, Schlumberger M. New therapeutic approaches for metastatic thyroid carcinoma. Lancet Oncol 2007;8:148-56.
-
(2007)
Lancet Oncol
, vol.8
, pp. 148-156
-
-
Baudin, E.1
Schlumberger, M.2
-
35
-
-
0028997547
-
Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades
-
Dinneen SF, Valimaki MJ, Bergstralh EJ, Goellner JR, Gorman CA, Hay ID. Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades. J Clin Endocrinol Metab 1995;80:2041-5.
-
(1995)
J Clin Endocrinol Metab
, vol.80
, pp. 2041-2045
-
-
Dinneen, S.F.1
Valimaki, M.J.2
Bergstralh, E.J.3
Goellner, J.R.4
Gorman, C.A.5
Hay, I.D.6
-
36
-
-
0023689451
-
Distant metastases in differentiated thyroid carcinoma. A multivariate analysis of prognosis variables
-
Ruegemer JJ, Hay ID, Bergstralh EJ, Ryan JJ, Offord KP, Gorman CA. Distant metastases in differentiated thyroid carcinoma. A multivariate analysis of prognosis variables. J Clin Endocrinol Metab 1988;67:501-8.
-
(1988)
J Clin Endocrinol Metab
, vol.67
, pp. 501-508
-
-
Ruegemer, J.J.1
Hay, I.D.2
Bergstralh, E.J.3
Ryan, J.J.4
Offord, K.P.5
Gorman, C.A.6
-
37
-
-
22044458191
-
Differentiated thyroid carcinoma with distant metastases at presentation: Prognostic factors and outcome
-
DOI 10.1111/j.1365-2265.2005.02304.x
-
Haq M, Harmer C. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome. Clin Endocrinol (Oxf) 2005;63:87-93. (Pubitemid 40966408)
-
(2005)
Clinical Endocrinology
, vol.63
, Issue.1
, pp. 87-93
-
-
Haq, M.1
Harmer, C.2
-
38
-
-
0030119620
-
Radioactive Iodine Treatment and External Radiotherapy for Lung and Bone Metastases from Thyroid Carcinoma
-
Schlumberger M, Challeton C, de Vathaire F, Travagli JP, Gardet P, Lumbroso JD et al. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med 1996;37:598-605. (Pubitemid 126618447)
-
(1996)
Journal of Nuclear Medicine
, vol.37
, Issue.4-6
, pp. 598-605
-
-
Schlumberger, M.1
Challeton, C.2
De Vathaire, F.3
Travagli, J.-P.4
Gardet, P.5
Lumbroso, J.-D.6
Francese, C.7
Fontaine, F.8
Ricard, M.9
Parmentier, C.10
-
39
-
-
34648834395
-
Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis
-
Sampson E, Brierley JD, Le LW, Rotstein L, Tsang RW. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis. Cancer 2007;110:1451-6.
-
(2007)
Cancer
, vol.110
, pp. 1451-1456
-
-
Sampson, E.1
Brierley, J.D.2
Le, L.W.3
Rotstein, L.4
Tsang, R.W.5
-
40
-
-
0034040689
-
Differentiated thyroid cancer: Clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group
-
La Quaglia MP, Black T, Holcomb GW 3rd, Sklar C, Azizkhan RG, Haase GM et al. Differentiated thyroid cancer: clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group. J Pediatr Surg 2000;35:955-9.
-
(2000)
J Pediatr Surg
, vol.35
, pp. 955-959
-
-
La Quaglia, M.P.1
Black, T.2
Holcomb III, G.W.3
Sklar, C.4
Azizkhan, R.G.5
Haase, G.M.6
-
41
-
-
0031710453
-
Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer
-
Samuel AM, Rajashekharrao B, Shah DH. Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer. J Nucl Med 1998;39:1531-6.
-
(1998)
J Nucl Med
, vol.39
, pp. 1531-1536
-
-
Samuel, A.M.1
Rajashekharrao, B.2
Shah, D.H.3
-
42
-
-
35948982277
-
131I-based detection on outcome
-
DOI 10.1677/ERC-07-0120
-
Hindié E, Zanotti-Fregonara P, Keller I, Duron F, Devaux JY, Calzada-Nocaudie M et al. Bone metastases of differentiated thyroid cancer: impact of early 131I-based detection on outcome. Endocr Relat Cancer 2007;14:799-807. (Pubitemid 350074068)
-
(2007)
Endocrine-Related Cancer
, vol.14
, Issue.3
, pp. 799-807
-
-
Hindie, E.1
Zanotti-Fregonara, P.2
Keller, I.3
Duron, F.4
Devaux, J.-Y.5
Calzada-Nocaudie, M.6
Sarfati, E.7
Moretti, J.-L.8
Bouchard, P.9
Toubert, M.-E.10
-
43
-
-
0027933714
-
Outcome of 309 patients with metastatic thyroid carcinoma treated with radioiodine
-
Pacini F, Cetani F, Miccoli P, Mancusi F, Ceccarelli C, Lippi F et al. Outcome of 309 patients with metastatic thyroid carcinoma treated with radioiodine. World J Surg 1994;18:600-4.
-
(1994)
World J Surg
, vol.18
, pp. 600-604
-
-
Pacini, F.1
Cetani, F.2
Miccoli, P.3
Mancusi, F.4
Ceccarelli, C.5
Lippi, F.6
-
44
-
-
17744368257
-
Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas
-
Bernier MO, Leenhardt L, Hoang C, Aurengo A, Mary JY, Menegaux F et al. Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas. J Clin Endocrinol Metab 2001;86:1568-73.
-
(2001)
J Clin Endocrinol Metab
, vol.86
, pp. 1568-1573
-
-
Bernier, M.O.1
Leenhardt, L.2
Hoang, C.3
Aurengo, A.4
Mary, J.Y.5
Menegaux, F.6
-
45
-
-
0022860216
-
Surgical treatment of distant metastases in differentiated thyroid cancer: Indication and results
-
Niederle B, Roka R, Schemper M, Fritsch A, Weissel M, Ramach W. Surgical treatment of distant metastases in differentiated thyroid cancer: indication and results. Surgery 1986;100:1088-97.
-
(1986)
Surgery
, vol.100
, pp. 1088-1097
-
-
Niederle, B.1
Roka, R.2
Schemper, M.3
Fritsch, A.4
Weissel, M.5
Ramach, W.6
-
46
-
-
0034085346
-
Bone metastases from thyroid carcinoma: Clinical characteristics and prognostic variables in one hundred forty-six patients
-
Pittas AG, Adler M, Fazzari M, Tickoo S, Rosai J, Larson SM et al. Bone metastases from thyroid carcinoma: clinical characteristics and prognostic variables in one hundred forty-six patients. Thyroid 2000;10:261-8.
-
(2000)
Thyroid
, vol.10
, pp. 261-268
-
-
Pittas, A.G.1
Adler, M.2
Fazzari, M.3
Tickoo, S.4
Rosai, J.5
Larson, S.M.6
-
47
-
-
0036226649
-
Long-term follow-up of patients with bone metastases from differentiated thyroid carcinoma surgery or conventional therapy?
-
Oxf
-
Zettinig G, Fueger BJ, Passier C, Kaserer K, Pirich C, Dudczak R et al. Long-term follow-up of patients with bone metastases from differentiated thyroid carcinoma surgery or conventional therapy? Clin Endocrinol (Oxf) 2002;56:377-82.
-
(2002)
Clin Endocrinol
, vol.56
, pp. 377-382
-
-
Zettinig, G.1
Fueger, B.J.2
Passier, C.3
Kaserer, K.4
Pirich, C.5
Dudczak, R.6
-
48
-
-
41149095035
-
Measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer
-
Spencer CA, Lopresti JS. Measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer. Nat Clin Pract Endocrinol Metab 2008;4:223-33.
-
(2008)
Nat Clin Pract Endocrinol Metab
, vol.4
, pp. 223-233
-
-
Spencer, C.A.1
Lopresti, J.S.2
-
49
-
-
0032238198
-
The use of radioactive iodine in patients with papillary and follicular thyroid cancer
-
Wartofsky L, Sherman SI, Gopal J, Schlumberger M, Hay ID. The use of radioactive iodine in patients with papillary and follicular thyroid cancer. J Clin Endocrinol Metab 1998;83:4195-203.
-
(1998)
J Clin Endocrinol Metab
, vol.83
, pp. 4195-4203
-
-
Wartofsky, L.1
Sherman, S.I.2
Gopal, J.3
Schlumberger, M.4
Hay, I.D.5
-
50
-
-
0043194337
-
Functioning pulmonary metastases of thyroid cancer: Does radioiodine influence the prognosis?
-
Hindié E, Melliere D, Lange F, Hallaj I, de Labriolle-Vaylet C, Jeanguillaume C et al. Functioning pulmonary metastases of thyroid cancer: does radioiodine influence the prognosis? Eur J Nucl Med Mol Imaging 2003;30:974-81.
-
(2003)
Eur J Nucl Med Mol Imaging
, vol.30
, pp. 974-981
-
-
Hindié, E.1
Melliere, D.2
Lange, F.3
Hallaj, I.4
De Labriolle-Vaylet, C.5
Jeanguillaume, C.6
-
51
-
-
0023697542
-
Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest X-rays
-
Schlumberger M, Arcangioli O, Piekarski JD, Tubiana M, Parmentier C. Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest X-rays. J Nucl Med 1988;29:1790-4.
-
(1988)
J Nucl Med
, vol.29
, pp. 1790-1794
-
-
Schlumberger, M.1
Arcangioli, O.2
Piekarski, J.D.3
Tubiana, M.4
Parmentier, C.5
-
52
-
-
0033457279
-
Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: Results of a multicentre study
-
Grünwald F, Kälicke T, Feine U, Lietzenmayer R, Scheidhauer K, Dietlein M et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study. Eur J Nucl Med 1999;26:1547-52.
-
(1999)
Eur J Nucl Med
, vol.26
, pp. 1547-1552
-
-
Grünwald, F.1
Kälicke, T.2
Feine, U.3
Lietzenmayer, R.4
Scheidhauer, K.5
Dietlein, M.6
-
53
-
-
33846898006
-
Should "low-risk" thyroid cancer patients with residual thyroglobulin be re-treated with iodine 131?
-
Oxf
-
Hindié E, Zanotti-Fregonara P, Duron F, Keller I, Bouchard P, Devaux JY. Should "low-risk" thyroid cancer patients with residual thyroglobulin be re-treated with iodine 131? Clin Endocrinol (Oxf) 2007;66:329-34.
-
(2007)
Clin Endocrinol
, vol.66
, pp. 329-334
-
-
Hindié, E.1
Zanotti-Fregonara, P.2
Duron, F.3
Keller, I.4
Bouchard, P.5
Devaux, J.Y.6
-
54
-
-
0029779869
-
Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer
-
Feine U, Lietzenmayer R, Hanke JP, Held J, Wöhrle H, Müller-Schauenburg W. Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer. J Nucl Med 1996;37:1468-72.
-
(1996)
J Nucl Med
, vol.37
, pp. 1468-1472
-
-
Feine, U.1
Lietzenmayer, R.2
Hanke, J.P.3
Held, J.4
Wöhrle, H.5
Müller-Schauenburg, W.6
-
55
-
-
32544437659
-
Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning
-
Robbins RJ, Wan Q, Grewal RK, Reibke R, Gonen M, Strauss HW et al. Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning. J Clin Endocrinol Metab 2006;91:498-505.
-
(2006)
J Clin Endocrinol Metab
, vol.91
, pp. 498-505
-
-
Robbins, R.J.1
Wan, Q.2
Grewal, R.K.3
Reibke, R.4
Gonen, M.5
Strauss, H.W.6
-
56
-
-
0020518295
-
Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer
-
Maxon HR, Thomas SR, Hertzberg VS, Kereiakes JG, Chen IW, Sperling MI et al. Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer. N Engl J Med 1983;309:937-41.
-
(1983)
N Engl J Med
, vol.309
, pp. 937-941
-
-
Maxon, H.R.1
Thomas, S.R.2
Hertzberg, V.S.3
Kereiakes, J.G.4
Chen, I.W.5
Sperling, M.I.6
-
57
-
-
16444375322
-
rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: A comprehensive review
-
Luster M, Lippi F, Jarzab B, Perros P, Lassmann M, Reiners C et al. rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review. Endocr Relat Cancer 2005; 12:49-64.
-
(2005)
Endocr Relat Cancer
, vol.12
, pp. 49-64
-
-
Luster, M.1
Lippi, F.2
Jarzab, B.3
Perros, P.4
Lassmann, M.5
Reiners, C.6
-
58
-
-
47549111595
-
Overview on the use of recombinant human thyrotropin in thyroid cancer of follicular cell origin
-
Zanotti-Fregonara P, Toubert ME, Taieb D, Ravasi L, Rubello D, Hindie E. Overview on the use of recombinant human thyrotropin in thyroid cancer of follicular cell origin. Minerva Endocrinol 2008;33:53-65.
-
(2008)
Minerva Endocrinol
, vol.33
, pp. 53-65
-
-
Zanotti-Fregonara, P.1
Toubert, M.E.2
Taieb, D.3
Ravasi, L.4
Rubello, D.5
Hindie, E.6
-
59
-
-
37249026112
-
Papillary thyroid carcinoma with distant metastases: Survival predictors and the importance of local control
-
DOI 10.1016/j.surg.2007.06.011, PII S0039606007003704
-
Sugitani I, Fujimoto Y, Yamamoto N. Papillary thyroid carcinoma with distant metastases: survival predictors and the importance of local control. Surgery 2008;143:35-42. (Pubitemid 350266026)
-
(2008)
Surgery
, vol.143
, Issue.1
, pp. 35-42
-
-
Sugitani, I.1
Fujimoto, Y.2
Yamamoto, N.3
-
60
-
-
0023603320
-
Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels
-
Pacini F, Lippi F, Formica N, Elisei R, Anelli S, Ceccarelli C et al. Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels. J Nucl Med 1987;28:1888-91.
-
(1987)
J Nucl Med
, vol.28
, pp. 1888-1891
-
-
Pacini, F.1
Lippi, F.2
Formica, N.3
Elisei, R.4
Anelli, S.5
Ceccarelli, C.6
-
62
-
-
25444455379
-
Radiofrequency ablation therapy combined with cementoplasty for painful bone metastases: Initial experience
-
Toyota N, Naito A, Kakizawa H, Hieda M, Hirai N, Tachikake T et al. Radiofrequency ablation therapy combined with cementoplasty for painful bone metastases: initial experience. Cardiovasc Intervent Radiol 2005;28:578-83.
-
(2005)
Cardiovasc Intervent Radiol
, vol.28
, pp. 578-583
-
-
Toyota, N.1
Naito, A.2
Kakizawa, H.3
Hieda, M.4
Hirai, N.5
Tachikake, T.6
-
63
-
-
0035875234
-
Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer
-
Vitale G, Fonderico F, Martignetti A, Caraglia M, Ciccarelli A, Nuzzo V et al. Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer. Br J Cancer 2001;84:1586-90.
-
(2001)
Br J Cancer
, vol.84
, pp. 1586-1590
-
-
Vitale, G.1
Fonderico, F.2
Martignetti, A.3
Caraglia, M.4
Ciccarelli, A.5
Nuzzo, V.6
-
64
-
-
0345303967
-
Second primary malignancies in thyroid cancer patients
-
Rubino C, de Vathaire F, Dottorini ME, Hall P, Schvartz C, Couette JE et al. Second primary malignancies in thyroid cancer patients. Br J Cancer 2003;89:1638-44.
-
(2003)
Br J Cancer
, vol.89
, pp. 1638-1644
-
-
Rubino, C.1
De Vathaire, F.2
Dottorini, M.E.3
Hall, P.4
Schvartz, C.5
Couette, J.E.6
-
65
-
-
39049152497
-
The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer
-
Brown AP, Chen J, Hitchcock YJ, Szabo A, Shrieve DC, Tward JD. The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer. J Clin Endocrinol Metab. 2008;93:504-15
-
(2008)
J Clin Endocrinol Metab
, vol.93
, pp. 504-515
-
-
Brown, A.P.1
Chen, J.2
Hitchcock, Y.J.3
Szabo, A.4
Shrieve, D.C.5
Tward, J.D.6
-
66
-
-
79961002271
-
131I in male patients with thyroid carcinoma
-
131I in male patients with thyroid carcinoma. Arch Androl. 2005;51:171-5.
-
(2005)
Arch Androl
, vol.51
, pp. 171-175
-
-
Krassas, G.E.1
Pontikides, N.2
-
67
-
-
44149117258
-
Therapeutic Administration of 131I for Differentiated Thyroid Cancer: Radiation Dose to Ovaries and Outcome of Pregnancies
-
Garsi JP, Schlumberger M, Rubino C, Ricard M, Labbé M, Ceccarelli C et al. Therapeutic Administration of 131I for Differentiated Thyroid Cancer: Radiation Dose to Ovaries and Outcome of Pregnancies. J Nucl Med J Nucl Med 2008;49:845-52.
-
(2008)
J Nucl Med J Nucl Med
, vol.49
, pp. 845-852
-
-
Garsi, J.P.1
Schlumberger, M.2
Rubino, C.3
Ricard, M.4
Labbé, M.5
Ceccarelli, C.6
-
68
-
-
37649007270
-
CELL-DOSE: A Monte Carlo code to assess electron dose distribution - S values for 131I in spheres of various sizes
-
Champion C, Zanotti-Fregonara P, Hindié E. CELL-DOSE: a Monte Carlo code to assess electron dose distribution - S values for 131I in spheres of various sizes. J Nucl Med 2008;49:151-7.
-
(2008)
J Nucl Med
, vol.49
, pp. 151-157
-
-
Champion, C.1
Zanotti-Fregonara, P.2
Hindié, E.3
-
69
-
-
0022355480
-
A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma
-
Shimaoka K, Schoenfeld DA, DeWys WD, Creech RH, DeConti R. A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma. Cancer 1985;56:2155-60.
-
(1985)
Cancer
, vol.56
, pp. 2155-2160
-
-
Shimaoka, K.1
Schoenfeld, D.A.2
DeWys, W.D.3
Creech, R.H.4
DeConti, R.5
-
70
-
-
0025916513
-
Combined chemotherapy with bleomycin, adriamycin, and platinum in advanced thyroid cancer
-
De Besi P, Busnardo B, Toso S, Girelli ME, Nacamulli D, Simioni N et al. Combined chemotherapy with bleomycin, adriamycin, and platinum in advanced thyroid cancer. J Endocrinol Invest 1991;14:475-80.
-
(1991)
J Endocrinol Invest
, vol.14
, pp. 475-480
-
-
De Besi, P.1
Busnardo, B.2
Toso, S.3
Girelli, M.E.4
Nacamulli, D.5
Simioni, N.6
-
71
-
-
0036739992
-
Cytotoxic effects of carboplatinum and epirubicin in the setting of an elevated serum thyrotropin for advanced poorly differentiated thyroid cancer
-
Santini F, Bottici V, Elisei R, Montanelli L, Mazzeo S, Basolo F et al. Cytotoxic effects of carboplatinum and epirubicin in the setting of an elevated serum thyrotropin for advanced poorly differentiated thyroid cancer. J Clin Endocrinol Metab 2002;87:4160-5.
-
(2002)
J Clin Endocrinol Metab
, vol.87
, pp. 4160-4165
-
-
Santini, F.1
Bottici, V.2
Elisei, R.3
Montanelli, L.4
Mazzeo, S.5
Basolo, F.6
-
72
-
-
0038605690
-
In-111 DTPA-octreotide scintigraphy for disease detection in metastatic thyroid cancer: Comparison with F-18 FDG positron emission tomography and extensive conventional radiographic imaging
-
Sarlis NJ, Gourgiotis L, Guthrie LC, Galen B, Skarulis MC, Shawker TH et al. In-111 DTPA-octreotide scintigraphy for disease detection in metastatic thyroid cancer: comparison with F-18 FDG positron emission tomography and extensive conventional radiographic imaging. Clin Nucl Med 2003;28:208-17.
-
(2003)
Clin Nucl Med
, vol.28
, pp. 208-217
-
-
Sarlis, N.J.1
Gourgiotis, L.2
Guthrie, L.C.3
Galen, B.4
Skarulis, M.C.5
Shawker, T.H.6
-
73
-
-
14844359800
-
Peptide receptor radionuclide therapy for non-radioiodine-avid differentiated thyroid carcinoma
-
Teunissen JJ, Kwekkeboom DJ, Kooij PP, Bakker WH, Krenning EP. Peptide receptor radionuclide therapy for non-radioiodine-avid differentiated thyroid carcinoma. J Nucl Med 2005;46(Suppl 1):107S-14S.
-
(2005)
J Nucl Med
, vol.46
, Issue.SUPPL. 1
-
-
Teunissen, J.J.1
Kwekkeboom, D.J.2
Kooij, P.P.3
Bakker, W.H.4
Krenning, E.P.5
-
74
-
-
0033058899
-
Lithium as a potential adjuvant to 131I therapy of metastatic, well differentiated thyroid carcinoma
-
Koong SS, Reynolds JC, Movius EG, Keenan AM, Ain KB, Lakshmanan MC et al. Lithium as a potential adjuvant to 131I therapy of metastatic, well differentiated thyroid carcinoma. J Clin Endocrinol Metab 1999;84:912-6.
-
(1999)
J Clin Endocrinol Metab
, vol.84
, pp. 912-916
-
-
Koong, S.S.1
Reynolds, J.C.2
Movius, E.G.3
Keenan, A.M.4
Ain, K.B.5
Lakshmanan, M.C.6
-
75
-
-
33646832056
-
Lithium as adjuvant to radioiodine therapy in differentiated thyroid carcinoma: Clinical and in vitro studies
-
Oxf
-
Liu YY, van der Pluijm G, Karperien M, Stokkel MP, Pereira AM, Morreau J et al. Lithium as adjuvant to radioiodine therapy in differentiated thyroid carcinoma: clinical and in vitro studies. Clin Endocrinol (Oxf) 2006;64:617-24.
-
(2006)
Clin Endocrinol
, vol.64
, pp. 617-624
-
-
Liu, Y.Y.1
Van Der Pluijm, G.2
Karperien, M.3
Stokkel, M.P.4
Pereira, A.M.5
Morreau, J.6
-
76
-
-
0031800394
-
Functional retinoid and thyroid hormone receptors in human thyroid-carcinoma cell lines and tissues
-
Schmutzler C, Brtko J, Winzer R, Jakobs TC, Meissner-Weigl J, Simon D et al. Functional retinoid and thyroid hormone receptors in human thyroid-carcinoma cell lines and tissues. Int J Cancer 1998;76:368-76.
-
(1998)
Int J Cancer
, vol.76
, pp. 368-376
-
-
Schmutzler, C.1
Brtko, J.2
Winzer, R.3
Jakobs, T.C.4
Meissner-Weigl, J.5
Simon, D.6
-
77
-
-
0034456589
-
All-trans-retinoic acid modulates expression levels of thyroglobulin and cytokines in a new human poorly differentiated papillary thyroid carcinoma cell line, KTC-1
-
Kurebayashi J, Tanaka K, Otsuki T, Moriya T, Kunisue H, Uno M et al. All-trans-retinoic acid modulates expression levels of thyroglobulin and cytokines in a new human poorly differentiated papillary thyroid carcinoma cell line, KTC-1. J Clin Endocrinol Metab 2000;85:2889-96.
-
(2000)
J Clin Endocrinol Metab
, vol.85
, pp. 2889-2896
-
-
Kurebayashi, J.1
Tanaka, K.2
Otsuki, T.3
Moriya, T.4
Kunisue, H.5
Uno, M.6
-
78
-
-
0038069524
-
Retinoic acid for redifferentiation of thyroid cancer - Does it hold its promise?
-
Gruning T, Tiepolt C, Zophel K, Bredow J, Kropp J, Franke WG. Retinoic acid for redifferentiation of thyroid cancer - does it hold its promise? Eur J Endocrinol 2003;148:395-402.
-
(2003)
Eur J Endocrinol
, vol.148
, pp. 395-402
-
-
Gruning, T.1
Tiepolt, C.2
Zophel, K.3
Bredow, J.4
Kropp, J.5
Franke, W.G.6
-
79
-
-
0031741959
-
Redifferentiation therapy-induced radioiodine uptake in thyroid cancer
-
Grunwald F, Menzel C, Bender H, Palmedo H, Otte R, Fimmers R et al. Redifferentiation therapy-induced radioiodine uptake in thyroid cancer. J Nucl Med 1998;39:1903-6.
-
(1998)
J Nucl Med
, vol.39
, pp. 1903-1906
-
-
Grunwald, F.1
Menzel, C.2
Bender, H.3
Palmedo, H.4
Otte, R.5
Fimmers, R.6
-
80
-
-
0036597118
-
Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: Final results of a pilot study
-
Simon D, Körber C, Krausch M, Segering J, Groth P, Görges R et al. Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results of a pilot study. Eur J Nucl Med Mol Imaging 2002;29:775-82.
-
(2002)
Eur J Nucl Med Mol Imaging
, vol.29
, pp. 775-782
-
-
Simon, D.1
Körber, C.2
Krausch, M.3
Segering, J.4
Groth, P.5
Görges, R.6
-
81
-
-
26744446442
-
Redifferentiation therapy with retinoids for radioiodine negative thyroid cancer patients
-
p S172
-
Toubert ME, Darsin D, Cassinat B, Tenenbaum F, Corone C, Rain JD et al. Redifferentiation therapy with retinoids for radioiodine negative thyroid cancer patients. Eur J Nucl Med Mol Imaging 2003;30:O106. p S172.
-
(2003)
Eur J Nucl Med Mol Imaging
, vol.30
-
-
Toubert, M.E.1
Darsin, D.2
Cassinat, B.3
Tenenbaum, F.4
Corone, C.5
Rain, J.D.6
-
82
-
-
33846459070
-
Defective efficacy of retinoic acid treatment in patients with metastatic thyroid carcinoma
-
Courbon F, Zerdoud S, Bastie D, Archambaud F, Hoff M, Eche N et al. Defective efficacy of retinoic acid treatment in patients with metastatic thyroid carcinoma. Thyroid 2006;16:1025-31.
-
(2006)
Thyroid
, vol.16
, pp. 1025-1031
-
-
Courbon, F.1
Zerdoud, S.2
Bastie, D.3
Archambaud, F.4
Hoff, M.5
Eche, N.6
-
83
-
-
40749092848
-
Radioiodine therapy after pretreatment with bexarotene for metastases of differentiated thyroid carcinoma
-
Oxf
-
Liu YY, Stokkel MP, Morreau HA, Pereira AM, Romijn JA, Smit JW. Radioiodine therapy after pretreatment with bexarotene for metastases of differentiated thyroid carcinoma. Clin Endocrinol (Oxf) 2008;68:605-9.
-
(2008)
Clin Endocrinol
, vol.68
, pp. 605-609
-
-
Liu, Y.Y.1
Stokkel, M.P.2
Morreau, H.A.3
Pereira, A.M.4
Romijn, J.A.5
Smit, J.W.6
-
84
-
-
34247620449
-
A clinical study of all-trans-retinoid-induced differentiation therapy of advanced thyroid cancer
-
Zhang Y, Jia S, Liu Y, Li B, Wang Z, Lu H et al. A clinical study of all-trans-retinoid-induced differentiation therapy of advanced thyroid cancer. Nucl Med Commun 2007;28:251-5.
-
(2007)
Nucl Med Commun
, vol.28
, pp. 251-255
-
-
Zhang, Y.1
Jia, S.2
Liu, Y.3
Li, B.4
Wang, Z.5
Lu, H.6
-
85
-
-
34249977889
-
Epigenetic patterns of the retinoic acid receptor beta2 promoter in retinoic acid-resistant thyroid cancer cells
-
Cras A, Darsin-Bettinger D, Balitrand N, Cassinat B, Soulie A, Toubert ME et al. Epigenetic patterns of the retinoic acid receptor beta2 promoter in retinoic acid-resistant thyroid cancer cells. Oncogene 2007;26:4018-24.
-
(2007)
Oncogene
, vol.26
, pp. 4018-4024
-
-
Cras, A.1
Darsin-Bettinger, D.2
Balitrand, N.3
Cassinat, B.4
Soulie, A.5
Toubert, M.E.6
-
86
-
-
39149083748
-
New insights in thyroid follicular cell biology and its impact in thyroid cancer therapy
-
Riesco-Eizaguirre G, Santisteban P. New insights in thyroid follicular cell biology and its impact in thyroid cancer therapy. Endocr Relat Cancer 2007;14:957-77.
-
(2007)
Endocr Relat Cancer
, vol.14
, pp. 957-977
-
-
Riesco-Eizaguirre, G.1
Santisteban, P.2
-
87
-
-
22044442973
-
Tyrosine kinases as targets for cancer therapy
-
Krause DS, Van Etten RA. Tyrosine kinases as targets for cancer therapy. N Engl J Med 2005;353:172-87.
-
(2005)
N Engl J Med
, vol.353
, pp. 172-187
-
-
Krause, D.S.1
Van Etten, R.A.2
-
88
-
-
9444277283
-
How thyroid tumors start and why it matters: Kinase mutants as targets for solid cancer pharmacotherapy
-
Fagin JA How thyroid tumors start and why it matters: kinase mutants as targets for solid cancer pharmacotherapy. J Endocrinol 2004;183:249-56.
-
(2004)
J Endocrinol
, vol.183
, pp. 249-256
-
-
Fagin, J.A.1
-
89
-
-
10744233716
-
Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia
-
DOI 10.1056/NEJMoa022457
-
O'Brien SG, Guilhot F, Larson RA, Gathmann I, Baccarani M, Cervantes F et al. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 2003;348:994-1004. (Pubitemid 36302244)
-
(2003)
New England Journal of Medicine
, vol.348
, Issue.11
, pp. 994-1004
-
-
O'Brien, S.G.1
Guilhot, F.2
Larson, R.A.3
Gathmann, I.4
Baccarani, M.5
Cervantes, F.6
Cornelissen, J.J.7
Fischer, T.8
Hochhaus, A.9
Hughes, T.10
Lechner, K.11
Nielsen, J.L.12
Rousselot, P.13
Reiffers, J.14
Saglio, G.15
Shepherd, J.16
Simonsson, B.17
Gratwohl, A.18
Goldman, J.M.19
Kantarjian, H.20
Taylor, K.21
Verhoef, G.22
Bolton, A.E.23
Capdeville, R.24
Druker, B.J.25
more..
-
90
-
-
40949130884
-
A Phase II Study of Gefitinib in Patients with Advanced Thyroid Cancer
-
Pennell NA, Daniels GH, Haddad RI, Ross DS, Evans T, Wirth LJ et al. A Phase II Study of Gefitinib in Patients with Advanced Thyroid Cancer. Thyroid 2008;18:317-23.
-
(2008)
Thyroid
, vol.18
, pp. 317-323
-
-
Pennell, N.A.1
Daniels, G.H.2
Haddad, R.I.3
Ross, D.S.4
Evans, T.5
Wirth, L.J.6
-
91
-
-
40949118479
-
Where Do We Stand with Targeted Therapy of Refractory Thyroid Cancer?-Utility of RECIST Criteria
-
Pacini F. Where Do We Stand with Targeted Therapy of Refractory Thyroid Cancer?-Utility of RECIST Criteria. Thyroid 2008;18:279-80.
-
(2008)
Thyroid
, vol.18
, pp. 279-280
-
-
Pacini, F.1
-
92
-
-
40549102299
-
Initial results from a phase II trial of motesanib diphosphate (AMG 706) in patients with differentiated thyroid cancer (DTC)
-
Sherman I, Schlumberger MJ, Droz J, Hoffmann M, Wirth L, Bastholt L et al. Initial results from a phase II trial of motesanib diphosphate (AMG 706) in patients with differentiated thyroid cancer (DTC). 2007 ASCO Annual Meeting Proceedings Part I. Vol. 25, No. 18S (June 20 Supplement), 2007:6017.
-
(2007)
2007 ASCO Annual Meeting Proceedings Part I
, vol.25
, Issue.18 S JUNE 20 SUPPL.
, pp. 6017
-
-
Sherman, I.1
Schlumberger, M.J.2
Droz, J.3
Hoffmann, M.4
Wirth, L.5
Bastholt, L.6
-
93
-
-
33749259546
-
Significant clinical and biologic activity of RAF/VEGF-R kinase inhibitor BAY 43-9006 in patients with metastatic papillary thyroid carcinoma (PTC): Updated results of a phase II study
-
Post-Meeting Edition
-
Kloos R, Ringel M, Knopp M, Heverhagen J, Rittenberry J, Weldy L et al. Significant clinical and biologic activity of RAF/VEGF-R kinase inhibitor BAY 43-9006 in patients with metastatic papillary thyroid carcinoma (PTC): Updated results of a phase II study. 2006 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol. 24, No. 18S (June 20 Supplement), 2006:5534.
-
(2006)
2006 ASCO Annual Meeting Proceedings
, vol.24
, Issue.18 S JUNE 20 SUPPL.
, pp. 5534
-
-
Kloos, R.1
Ringel, M.2
Knopp, M.3
Heverhagen, J.4
Rittenberry, J.5
Weldy, L.6
-
94
-
-
37349031805
-
Sorafenib targets BRAF and VEGFR in metastatic thyroid carcinoma
-
Post-Meeting Edition
-
Gupta V, Puttaswamy K, Lassoued W, Redlinger M, Ransone K, Gold K et al. Sorafenib targets BRAF and VEGFR in metastatic thyroid carcinoma. 2007 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 25, No 18S (June 20 Supplement), 2007:6019.
-
(2007)
2007 ASCO Annual Meeting Proceedings
, vol.25
, Issue.18 S JUNE 20 SUPPL.
, pp. 6019
-
-
Gupta, V.1
Puttaswamy, K.2
Lassoued, W.3
Redlinger, M.4
Ransone, K.5
Gold, K.6
-
95
-
-
36348992207
-
A phase II study of axitinib (AG-013736 [AG]) in patients (pts) with advanced thyroid cancers
-
Cohen EE, Vokes EE, Rosen LS, Kies MS, Forastiere AA, Worden FP et al. A phase II study of axitinib (AG-013736 [AG]) in patients (pts) with advanced thyroid cancers 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S (June 20 Supplement), 2007:6008.
-
(2007)
2007 ASCO Annual Meeting Proceedings Part I
, vol.25
, Issue.18 S JUNE 20 SUPPL.
, pp. 6008
-
-
Cohen, E.E.1
Vokes, E.E.2
Rosen, L.S.3
Kies, M.S.4
Forastiere, A.A.5
Worden, F.P.6
-
96
-
-
34548189195
-
Phase II trial of thalidomide for therapy of radioiodine-unresponsive and rapidly progressive thyroid carcinomas
-
Ain KB, Lee C, Williams KD. Phase II trial of thalidomide for therapy of radioiodine-unresponsive and rapidly progressive thyroid carcinomas. Thyroid 2007;17:663-70.
-
(2007)
Thyroid
, vol.17
, pp. 663-670
-
-
Ain, K.B.1
Lee, C.2
Williams, K.D.3
-
97
-
-
33744961755
-
Phase II study of celecoxib in metastatic differentiated thyroid carcinoma
-
Mrozek E, Kloos RT, Ringel MD, Kresty L, Snider P, Arbogast D et al. Phase II study of celecoxib in metastatic differentiated thyroid carcinoma. J Clin Endocrinol Metab 2006;91:2201-4.
-
(2006)
J Clin Endocrinol Metab
, vol.91
, pp. 2201-2204
-
-
Mrozek, E.1
Kloos, R.T.2
Ringel, M.D.3
Kresty, L.4
Snider, P.5
Arbogast, D.6
-
98
-
-
29244454573
-
Radiation combined with antiangiogenic and antivascular agents
-
O'Reilly MS. Radiation combined with antiangiogenic and antivascular agents. Semin Radiat Oncol 2006;16:45-50.
-
(2006)
Semin Radiat Oncol
, vol.16
, pp. 45-50
-
-
O'Reilly, M.S.1
-
99
-
-
2542561964
-
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
-
Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350:2335-42.
-
(2004)
N Engl J Med
, vol.350
, pp. 2335-2342
-
-
Hurwitz, H.1
Fehrenbacher, L.2
Novotny, W.3
Cartwright, T.4
Hainsworth, J.5
Heim, W.6
|